[The importance of fluoroquinolones in treating pneumonia in the elderly].
Belousov
Iu B
IuB
Chair of Clinical Pharmacology, Russia State Medical University, Moscow.
Efremenkova
O V
OV
Sokolov
A V
AV
Tishenkova
I F
IF
D000368:Aged; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy / Q000378:metabolism; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D024841:Fluoroquinolones; D006801:Humans; D008875:Middle Aged; D015242:Ofloxacin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000378:metabolism; D015363:Quinolones / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013183:Sputum / Q000378:metabolism; D013997:Time Factors
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D015242:Ofloxacin; C053091:lomefloxacin